A Closer Look at 3 Oncology Payment Reform Projects

October 28th 2020, 12:44pm


Evolution and collaboration are the fundamentals of bringing oncology payment reform plans to fruition, say 3 professionals on the front lines.

Cancer Does Not Stop for COVID-19, but Reform Becomes a Challenge

October 28th 2020, 12:00pm


During a session on day 1 of the Community Oncology Alliance (COA) Virtual Payer Exchange Summit on Oncology Payment Reform, a panel of experts discussed the ways COVID-19 continues to impact cancer care and payment reform.

Dr Andre Goy Discusses Potential Benefits of Earlier Use of CAR T Therapies

October 25th 2020, 11:00am


Andre Goy, MD, chairman, director, and chief of the Division of Lymphoma at John Theurer Cancer Center in Hackensack, NJ, discussed the potential benefits of using CAR T-cell therapies as a second-line treatment.

Areas to Watch in Specialty Drug Pipeline Include Cancer, Orphan Drugs

October 23rd 2020, 8:35pm


In her presentation, Aimee Tharaldson, PhD, senior clinical pharmacist of emerging therapeutics at Express Scripts, discussed the upcoming pipeline of specialty drug approvals and their potential impact on the market.

Experts Discuss Oncology Care and Payment Reform in Avalere Webinar

October 22nd 2020, 9:00pm


Experts in cancer care and payment discussed the future of oncology care in a panel discussion hosted by Avalere Health on October 21, 2020.

Dr David Jackman on Dana Farber's Clinical Pathway Development Process

October 21st 2020, 5:00pm


At Dana Farber Cancer Institute, essential steps to developing clinical pathways include engaging physicians to buy-in, finding the optimal platform to store data, and displaying resulting content in a supportive and efficient way.

Hodgkin Lymphoma Patients Face Noncancer Death Risk Despite Modern Therapies

October 16th 2020, 1:15pm


A study and accompanying editorial from the Journal of Clinical Oncology found that Hodgkin lymphoma survivors still face a higher risk of non-cancer death than the general population.

Dr Sara Douglas: Distance Caregivers of Patients With Cancer Have Distinct Needs

October 11th 2020, 12:00pm


Distance caregivers have unique needs, explained Sara L. Douglas, PhD, RN, the Gertrude Perkins Oliva Professor in Oncology Nursing, associate dean for research, the Frances Payne Bolton School of Nursing, Case Western Reserve University.

Phase 2 Trial to Study Palbociclib in Early Stage Breast Cancer Based on ctDNA Monitoring

October 10th 2020, 2:00pm


Natera’s Signatera ctDNA test will determine study eligibility and treatment effectiveness in HR-positive, HER2-negative breast cancer patients.

Dr Karen Winkfield on Improving Minority Access, Education for Precision Oncology

October 4th 2020, 12:00pm


Addressing gaps in testing and education within precision oncology can assist in improving access to patients of color and other underserved populations.